Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.76 USD -0.26 USD ( -3.24% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

Gross Margin

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides.

The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Current Gross Margin
ADCT
97.6%
Average Gross Margin
ADCT
64.4%
Industry Gross Margin
Biotechnology
64.9%

Gross Margin History

Statistics
Gross Margin

1 Year 3 Years 5 Years
Average 77.3% 64.4% 64.4%
Median 96.3% 96.1% 96.1%
Min 0% 0% 0%
Max 97.6% 97.6% 97.6%

History Chart
Gross Margin

Gross Margin Across Competitors

Gross Margin Comparison
ADC Therapeutics SA Competitors

Country Company Market Cap Gross
Margin
CH
ADC Therapeutics SA
NYSE:ADCT
596M USD
98%
US
Abbvie Inc
NYSE:ABBV
268B USD
70%
US
Amgen Inc
NASDAQ:AMGN
130B USD
75%
AU
CSL Ltd
ASX:CSL
131B AUD
55%
US
Gilead Sciences Inc
NASDAQ:GILD
78.1B USD
76%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
70.6B USD
88%
Country CH
Market Cap 596M USD
Gross Margin
98%
Country US
Market Cap 268B USD
Gross Margin
70%
Country US
Market Cap 130B USD
Gross Margin
75%
Country AU
Market Cap 131B AUD
Gross Margin
55%
Country US
Market Cap 78.1B USD
Gross Margin
76%
Country US
Market Cap 70.6B USD
Gross Margin
88%

Profitability Report

View the profitability report to see the full profitability analysis for ADC Therapeutics SA.

See Also

Similar Stocks